Empire Financial Management Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-57,831
Closed -$1.62M 194
2026
Q1
$1.62M Sell
57,831
-73,010
-56% -$1.94M 0.37% 76
2025
Q4
$3.26M Sell
130,841
-15,985
-11% -$403K 0.71% 51
2025
Q3
$3.74M Buy
146,826
+74,999
+104% +$1.85M 0.86% 36
2025
Q2
$1.74M Sell
71,827
-35
-0% -$816 0.5% 64
2025
Q1
$1.82M Sell
71,862
-333
-0.5% -$8.71K 0.56% 59
2024
Q4
$1.92M Sell
72,195
-23,109
-24% -$627K 0.6% 56
2024
Q3
$2.76M Buy
95,304
+1,000
+1% +$29.2K 0.85% 36
2024
Q2
$2.64M Sell
94,304
-6,468
-6% -$178K 0.87% 32
2024
Q1
$2.8M Buy
100,772
+37,841
+60% +$1.05M 0.92% 29
2023
Q4
$1.81M Buy
62,931
+7,200
+13% +$218K 0.71% 46
2023
Q3
$1.85M Sell
55,731
-10,754
-16% -$380K 0.81% 36
2023
Q2
$2.44M Sell
66,485
-1,500
-2% -$58.4K 0.97% 32
2023
Q1
$2.77M Buy
+67,985
New +$2.94M 1.13% 27

Other funds holding PFE

Empire Financial Management Company's PFE Position: Q2 2026 in Review

Empire Financial Management Company sold out of Pfizer (PFE) in Q2 2026, closing a stake of 57,831 shares — an estimated $1.62M sold.

Empire Financial Management Company first reported a position in PFE in Q1 2023 and held it in 13 quarters. The position peaked at $3.74M in Q3 2025. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Empire Financial Management Company reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Empire Financial Management Company sold 57,831 Pfizer shares in Q2 2026, an estimated $1.62M.
  • Empire Financial Management Company first reported a position in Pfizer in Q1 2023 and held it in 13 quarters.
  • Empire Financial Management Company's Pfizer position peaked at $3.74M in Q3 2025.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.